jiangsu Hengrui

New Business

Chinese biotech’s mega drug-licensing deals with multinationals surge on cost savings

A potential multibillion-dollar deal unveiled on Friday by CSPC Pharmaceutical Group is the latest in a growing number of agreements…

Read More »
New Business

Muyuan, BASiC, FS.com, Seer and Worldwide file to raise capital in Hong Kong’s IPO flurry

Five mainland companies have filed preliminary listing applications with the Hong Kong stock exchange to raise capital, joining the flurry…

Read More »
Tech

Coronavirus in China: 2021 outlook brightens for health care operators, pharmaceutical and device makers after price cuts

An MSCI index tracking 81 Chinese health care stocks with a combined market value of HK$1.15 trillion (US$148 billion) advanced…

Read More »
Back to top button